SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-019133
Filing Date
2019-05-14
Accepted
2019-05-14 16:06:27
Documents
54
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q life-10q_20190331.htm 10-Q 1597521
2 EX-10.2 life-ex102_52.htm EX-10.2 137956
3 EX-31.1 life-ex311_7.htm EX-31.1 9629
4 EX-31.2 life-ex312_10.htm EX-31.2 9130
5 EX-32.1 life-ex321_9.htm EX-32.1 5505
6 EX-32.2 life-ex322_8.htm EX-32.2 5494
7 GRAPHIC gtizxco2xprd000002.jpg GRAPHIC 5506
8 GRAPHIC gtizxco2xprd000001.jpg GRAPHIC 5370
  Complete submission text file 0001564590-19-019133.txt   5803362

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT life-20190331.xml EX-101.INS 1192255
10 XBRL TAXONOMY EXTENSION SCHEMA life-20190331.xsd EX-101.SCH 44565
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE life-20190331_cal.xml EX-101.CAL 43626
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE life-20190331_def.xml EX-101.DEF 180857
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE life-20190331_lab.xml EX-101.LAB 350638
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE life-20190331_pre.xml EX-101.PRE 275034
Mailing Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121 858-731-8389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37378 | Film No.: 19822711
SIC: 2836 Biological Products, (No Diagnostic Substances)